Investors see opportunity to profit from people's mistake...
- Forums
- ASX - By Stock
- IMM
- Ann: Ulcerative Colitis Phase II Study of GSK2831781 Discontinued
IMM
immutep limited
Add to My Watchlist
0.00%
!
26.0¢

Ann: Ulcerative Colitis Phase II Study of GSK2831781 Discontinued, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
26.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $387.0M |
Open | High | Low | Value | Volume |
26.0¢ | 27.0¢ | 26.0¢ | $702.4K | 2.631M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
29 | 259066 | 26.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.5¢ | 296164 | 34 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
29 | 265441 | 0.260 |
14 | 354329 | 0.255 |
16 | 248380 | 0.250 |
10 | 394783 | 0.245 |
18 | 268230 | 0.240 |
Price($) | Vol. | No. |
---|---|---|
0.265 | 290441 | 33 |
0.270 | 410784 | 13 |
0.275 | 389750 | 7 |
0.280 | 63572 | 7 |
0.285 | 43054 | 5 |
Last trade - 14.29pm 18/07/2025 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |